New study finds that resveratrol can help with insulin sensitivity
For the randomized, double-blind, placebo-controlled study, the scientists selected 19 diabetic men and women, who had no other health problems. Each of the participants was randomly assigned an oral supplement of 5mg resveratrol, taken twice daily, or a matching placebo for four weeks.
The researchers took blood and urine samples at baseline, the end of the second week, and upon completion of the 4-week trial. The researchers measured and statistically analysed insulin resistance/sensitivity, incretin levels and glucose metabolism.
The researchers noted that after the fourth week “resveratrol significantly decreased insulin resistance” while it simultaneously increased glucose metabolism and decreased oxidation.
A Biotivia spokesperson welcomed these results, saying: “It is fantastic to see more human studies taking place into the health applications of resveratrol. We have been involved in a similar glucose intolerance study with the Albert Einstein Medical Center using our Transmax resveratrol, and this to came back with very positive results.”
Transmax is Biotivia’s best selling resveratrol supplement. Each capsule contains 500mg of 98% pure trans-resveratrol and contains no inert fillers or additives. Resveratrol first came to light when Dr Sinclair of Harvard published his well received article on how this molecule could activate the signalling pathways of the SIRT1 gene, an anti-aging process that extends the cells life.
Biotivia went onto say: “We hope that the results from this Hungarian study will provide more confidence to medical research organisations to further look into the potential healing applications of resveratrol. We are involved with several medical research organisations who are investigating resveratrols effect on Thalasemia, cognitive function and type 2 diabetes; with the results being published in the near future which we hope will all be positive.
To read more about Transmax please visit http://www.biotivia.com/transmaxresveratrol.html
About Biotivia LLC
Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and biologically active botanics to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world’s leading developers and suppliers of unique science-based nutritional supplements and award winning skin care therapies, with most of their products centered around the use of concentrated resveratrol and complementary botanical extracts.
Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi’an, China and Mumbai, India.
Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center, Health Canada, and the University of California. Transmax and Bioforte in particular are being investigated by several major university medical schools as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world. Biotivia most recently signed an agreement to supply Transmax to the University of Ferrara for use in three human clinical trials in Italy and Egypt on its possible use by Thalassemia sufferers as an alternative to the whole blood transfusions which such patients now require monthly. The Albert Einstein Medical College published a study which elucidated the beneficial effects of Biotivia’s proprietary resveratrol on glucose tolerance and mitochondria function in pre-diabetic subjects. Bioforte was also shown to more than double brain blood flow in a study done at the University of Northumbria in the UK.
Biotivia’s resveratrol products, Transmax and Bioforte, have been independently assessed by a leading American quality watchdog, and were deemed both ‘most potent’ and ‘best value’. Transmax has been certified as an investigational drug by the NIH, an endorsement of its safety and purity.
Most of Biotivia’s supplements have been certified Vegan by the American Vegetarian Association.
Important Caveat: Neither Bio Shape nor any Biotivia product has been definitively shown to diagnose, prevent or cure any age related diseases. Bio Shape is not intended to diagnose, prevent, treat or cure any disease. Studies done in vitro and on animals do not always translate into the same biological effect when taken by human subjects. The statements herein have not been reviewed or approved by the US FDA. All Biotivia supplements are manufactured in state of the art government inspected pharmaceutical facilities in accordance with CGMP and USP standards.
Other press releases from Biotivia Bioceuticals LLC
- Anti-diabetic potential of resveratrol shown in study - September 2nd, 2011
- Biotivia Launch New Pterostilbene Supplement Called PteroActiv - August 23rd, 2011
- Resveratrol Could Benefit Type 2 Diabetics - August 23rd, 2011
- PteroActiv, the new pterostilbene supplement from Biotivia - August 16th, 2011
- Bowel Disorders Can Be Eased With Probiotic Supplements - August 16th, 2011
Contact InformationLeo Day
Title: Marketing Consultant
Biotivia Bioceuticals LLC